INTERNATIONAL PATENT: PACYLEX PHARMACEUTICALS INC. FILES APPLICATION FOR "ORAL PCLX-001 IN THE TREATMENT OF HUMAN CANCER"

GENEVA, March 16 -- PACYLEX PHARMACEUTICALS INC. (400 3rd Avenue SWSuite 3700Calgary, Alberta T2P 4H2) filed a patent application (PCT/CA2024/051151) for "ORAL PCLX-001 IN THE TREATMENT OF HUMAN CANCER" on Sep 05, 2024. With publication no. WO/2025/050208, the details related to the patent application was published on Mar 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MACKEY, John Robert (1665 Fawn Run DriveKelowna, British Columbia V1W 5M8), DAVIES, Neal Maynard (2549 Cameron Ravine LandingEdmonton, Alberta T6M 0L2)

Abstract: There is described herein a method for treating cancer in...